Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001288365 | SCV001475427 | uncertain significance | not provided | 2019-11-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002486085 | SCV002790630 | uncertain significance | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-07-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001288365 | SCV003930251 | uncertain significance | not provided | 2023-05-17 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004035560 | SCV004945837 | uncertain significance | Inborn genetic diseases | 2024-02-27 | criteria provided, single submitter | clinical testing | The c.4963C>T (p.R1655C) alteration is located in exon 34 (coding exon 34) of the RYR1 gene. This alteration results from a C to T substitution at nucleotide position 4963, causing the arginine (R) at amino acid position 1655 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |